Nuclear cardiology is no longer just diagnostic — it is increasingly guiding therapeutic decisions across cardiovascular care. Growth in precision diagnostics is driving demand for advanced molecular imaging, CT-based solutions, PET, and emerging applications such as cardiac amyloidosis and sarcoidosis imaging. But these advances are arriving at a time of mounting pressure for imaging programs.